Kymera Therapeutics, Inc. vs UnitedHealth Group Incorporated — Stock Comparison

KYMR
Kymera Therapeutics, Inc.
$80.71
▼ 0.44%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
UnitedHealth Group Incorporated
UNH6.3/10vs 5.8/10

Q·Score Breakdown

5.8
Neutral
Overall
6.3
Neutral
1.7
Quality
6.2
8.2
Health
5.3
6.1
Growth
5.1
6
Valuation
7.3
8.9
Sentiment
8.1
KYMR

96% of 23 covering analysts have a positive rating.

low return on equity (-27%).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $118.86 (+47.3%)
21 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

KYMR
UNH
Trailing P/E
27.9×
-19.9×
Forward P/E
17.8×
0.0%
Profit Margin
2.7%
0.0%
Gross Margin
18.8%
-27.1%
ROE
12.2%
55.5%
Revenue Growth
2.0%
Earnings Growth
0.7%
Beta
0.41
Price / Book
$6.6B
Market Cap
$334.9B
$28 – $103
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →